Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-25

Clinical Trial Update: Impact of Malnutrition on Pharmacokinetic of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children (TB-Speed TB-PK)

View source ↗

Summary

A completed clinical trial examines how malnutrition affects the pharmacokinetics of four first-line TB drugs (Rifampicin, Isoniazid, Pyrazinamide, and Ethambut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethambutol (ethambutol)
  • ISONIAZID (ISONIAZID)
  • Pyrazinamide (pyrazinamide)
  • Rifampicin

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Tuberculosis, Pulmonary | Status: COMPLETED